Research & Development: Page 74

PharmaVoice Team/PharmaVoice

Letter from the Editor

PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, Number Nine Ph...
By Taren Grom • March 18, 2008
PharmaVoice Team/PharmaVoice

Global Opportunities

According to Ernst & Young, the sheer volume and growing economic muscle of consumers in emerging markets provide powerful investment incentives for multinational companies (MNCs). In particular, current and projected growth rates for pharmaceutical markets in the BRIC countries and Mexico ex...
By Robin Robinson • March 2, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

Last Word

Alan C. Moses, M.D., is VP, Chief Medical Officer Worldwide, Novo Nordisk Inc. He has a broad and indepth background in diabetes research and specialization. Previously, Dr. Moses was Senior VP and Chief Medical Officer at the Joslin Diabetes Center and joined Novo Nordisk in April 2004 as Associ...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Wendy KOUBA Wyeth Names Communications VP Wyeth, Madison, N.J., has promoted Wendy Kouba to VP, cor porate communications, from VP, communica tions, technical operations and product supply. In this new role, Ms. Kouba oversees the company’s global public relations and communications f...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

March 1718 3rd Imaging in Preclinical &Clinical Drug Development San Diego For more information, contact Vivian Frankel, GTCBio, at 6262566405, email [email protected], or visit gtcbio.com. March 1718 The Inaugural U.S.Conference on Comparator Studies Doubletree Hotel,Philadelphia For...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Edge Dynamics has added a flexible desktop module within its Demand Management Suite that offers lifesciences manufacturers a way to easily monitor and analyze channel activity data for their products. The Edge Dynamics Demand Dash...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

What's New

WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES HealthEd Group has launched HealthEd Encore, which operates as a standalone agency, in response to increas ing client demand for educational patient marketing campaigns. HealthEd Encore offers a fullrange of ser vices, including c...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Best practices in planning and targeting and conducting office calls, as well as management of relationships, samples, programs, and salesforces are explored. These include the use of automated for mulary data and thoughtleader information to develop sales messages that anticipate formulary restr...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

Research collaborations can be a very useful adjunct to a company’s scientific investigations. They can expand their intellectual property portfolios, speed up the entry of molecules into the clinic, and possibly enhance their future revenue streams. In fact, there may be times when your company’...
By Dr. Stewart Lyman • March 2, 2008
PharmaVoice Team/PharmaVoice

A Woman's Heart

Women are six times more likely to die from heart attacks than breast cancer. Car diovascular diseases (CVD), particularly coronary heart disease (CHD) and stroke, remain the leading causes of death of women in America and most developed coun tries, with almost 39% of all female deaths in the Uni...
By Cynthia Borda • March 2, 2008
PharmaVoice Team/PharmaVoice

Strengthening the Clinical Recruitment Chain

W finding the right population within the right time frame means doing your homework, looking at feasibility data, modeling time frames, metrics, and budget parameters.” Negative press is another uncontrollable factor that can slow patient enrollment, par ticularly if a drug is pulled from the ma...
By Robin Robinson • Feb. 26, 2008
PharmaVoice Team/PharmaVoice

UpFront

DETAILING DUDS Rep Access Continues to Fall Based on a comprehensive telephone survey of 180,000 doctors, almost one fifth of U.S. officebased physicians refuse to see sales representatives from the drug and device industry at any time, according to SK&A Information Services. Another 22.7% of...
By PharmaVoice Team • Feb. 26, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

It may not be Jules Verne’s rendition of “Around the World in 80 days,” but for many pharmaceutical company managers it’s time to brush up on their language skills and make sure their passports are in order. The world is definitely getting smaller. Companies that were once aligned as being multin...
By Taren Grom • Feb. 26, 2008
PharmaVoice Team/PharmaVoice

Last Word

Michael Naimoli is U.S. Life Sciences Industry Solutions Director for Microsoft, and he has extensive insight into the challenges the industry faces with regard to document regulation and submission management as well as other quality control and business challenges. Before joining Microsoft, Mr....
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Dr. Michael E. KAMARCK Dr. Michael D. KOWOLENKO Joseph M. MAHADY Cavan M.REDMOND Douglas A. ROGERS Wyeth Hires and Promotes Executives Wyeth, Madison, N.J., has announced a number of executive hires and promotions at its pharmaceuticals and consumer health divisions. At Wyeth Pharmace...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

February 19 5th Annual Headache Research Summit Scottsdale,Ariz. For more information, contact National Headache Foundation, via email [email protected], or visit headaches.org. February 1921 Marketing Pharmaceuticals in aTime of Change NewYork Marriott Marquis Hotel,NewYork For more information...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Octagon Research Solutions Inc. has unveiled ViewPoint for Document Management, a solution that com bines existing Octagon document management, authoring tem plates, and document standards in a preconfigured environment designed to...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

What's New

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Medical Simulation Corp (MSC) has introduced the SimSuite Collegiate Sales Force Training Program to help organizations provide their salesforces with the clinical competence and cred ibility needed to engage physicians beyond the sales scri...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Managing Investigator Initiated Trials

Investigator initiated trials (IITs) can be a valuable part of a pharmaceutical or medical device manufacturer’s marketing claims arsenal, according to Rita Numerof, Ph.D., president, and Mark Morgan, M.S., senior business analyst, at Numerof & Associates Inc. The two contend that IITs are re...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Conquering the Divide — Joseph Pieroni

BY KIM RIBBINK Drawn initially to the lab as a medicinal chemist,then to the business side of pharma research, Joseph P. Pieroni has been able to straddle the often divided worlds of research and marketing seamlessly. This combination of skills and interests is great news for Daiichi Sankyo Inc.,...
By Kim Ribbink • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Super Bugs

Bacteria have proven to be resourceful organisms. They are so resourceful that the widespread use of antibiotics in recent years has enabled bacteria to adapt and develop resistance to currently marketed treatments. Antibiotics stop infection and the spread of infection, yet they also eventually ...
By Cynthia Borda • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

MSLs: Evolution of Skills

The intent of the first MSL role, created in 1967 by the Upjohn Company, was to create a position within the pharmaceutical company that could interact with academiabased physicians and researchers. In the 1970s, the trend grew, with other companies mostly implementing MSL hir ing from within the...
By Robin Robinson • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Gene Therapy Research Makes Progress

With all the progress that has been made in genomics, targeting therapies to correct the defective genes responsible for disease seems quite realistic. But developing commercial gene therapies to treat diseases through modifying the expressions of an individual’s genes or correcting abnormal gene...
By Denise Myshko • Jan. 29, 2008
PharmaVoice Team/PharmaVoice

UpFront

THE PRICE IS RIGHT Drug Pricing Decisions More Critical Than Ever In aneraofmore competition from generics, expiring patent protection for many topselling drugs, and a slowdown in new drug discoveries, there is very little margin for error in drug pricing decisions. Kalorama Information’s recent ...
By PharmaVoice Team • Jan. 29, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Wh o w o u l d h a v e thought that in 10 short years, we would have gone from Dolly to Elsie? In February 1997, scientists in Scotland announced the birth of the world’s first successfully cloned mammal, Dolly the sheep. Dolly, which was created at the Roslin Institute in Edinburgh, was actually...
By Taren Grom • Jan. 29, 2008